Dr. Michalopoulos is professor and chairman of the department of Pathology at the University of Pittsburgh. He obtained his MD from Athens, Greece and his Ph.D. and Pathology residency from University of Wisconsin. Dr. Michalopoulos joined Duke University as an Assistant Professor in 1977. In 1991, he moved to Pittsburgh and joined the university faculty in April of 1991. In addition to his current appointment, Dr. Michalopoulos also served as Associate Vice Chancellor for Health Sciences and Interim Dean of the School of Medicine from November of 1995-1998. The laboratory of Dr. Michalopoulos led the studies associated with the discovery of HGF (hepatocyte growth factor) and its receptor (c-Met). His research has focused on the molecular events involving growth factor and ECM signaling leading to initiation and termination of liver regeneration, and the molecular pathways controlling differentiation of hepatic cells. Pathways associated with termination of liver regeneration involve extracellular matrix signaling. Pathways involving formation of hepatocellular carcinomas are associated with signaling molecules involved in hepatocyte growth regulation. Dr. Michalopoulos has received a Merit Award from NIH. He was the Chair of the Board of Scientific Counselors of NIH Institute NIAAA. He was inducted as a fellow in the American Association for the Advancement of Science in 2007. He is the recipient of the Rous-Whipple Award in Experimental Pathology for 2009, the Distinguished Research Award by the American Liver Foundation in 2010 and an Honorary Doctorate degree from the University of Athens, Greece in 2013.